April 12, 2019 Conference
Modern cataract surgery and advanced technology intraocular lens (IOL) options provide not only improved vision and quality of life, but also the possibility of reduced spectacle dependence from astigmatism and/or presbyopia correction. Comorbid ocular pathology, however, can decrease refractive outcome predictability and degrade vision quality, especially with multifocal IOLs. Fuchs' dystrophy is a bilateral cornea endothelial disorder that can present on a spectrum - with minimal findings and no associated symptoms to profound corneal edema and vision loss.
What happens when advanced technology IOL results are compromised by Fuchs’ dystrophy or corneal edema? What can be done if Fuchs’ dystrophy or corneal edema is present and patients desire premium IOL outcomes?
This presentation discusses several such cases.